From 22 to 26 February 2023 in Orlando, Florida Presentation of preclinical data demonstrating how Batten-1 drastically reduces the buildup of toxic glycosphingolipids in Batten disease and a poster describing for the first time the burden of Batten disease. LYON, FRANCE and AUSTIN, TX and CARDIFF, UK / ACCESSWIRE / February 21, 2023 / Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in